Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AMLCourtney D. DiNardo, Hagop M. Kantarjian, Jessica K. Altman et al.|New England Journal of Medicine|2018Cited by 1.4k
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone diseaseSonia Vallet, Noopur Raje, Siddhartha Mukherjee et al.|Proceedings of the National Academy of Sciences|2010Cited by 235